Avandaryl and Skin blushing/flushing - a phase IV clinical study of FDA data


Skin blushing/flushing is found among people who take Avandaryl, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Avandaryl and have Skin blushing/flushing. It is created by eHealthMe based on reports of 2,654 people who have side effects when taking Avandaryl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On May, 20, 2022

2,654 people reported to have side effects when taking Avandaryl.
Among them, 11 people (0.41%) have Skin blushing/flushing.

What is Avandaryl?

Avandaryl has active ingredients of glimepiride; rosiglitazone maleate. It is often used in diabetes. eHealthMe is studying from 2,660 Avandaryl users for its effectiveness, alternative drugs and more.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 3,126 drugs and 2,615 conditions by eHealthMe.

Number of Avandaryl and Skin blushing/flushing reports submitted per year:

Could Avandaryl cause Skin blushing/flushing?

Gender of people who have Skin blushing/flushing when taking Avandaryl *:

  • female: 54.55 %
  • male: 45.45 %

Age of people who have Skin blushing/flushing when taking Avandaryl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 42.86 %
  • 60+: 57.14 %

Common drugs people take besides Avandaryl *:

  1. Simcor: 4 people, 36.36%
  2. Niaspan: 4 people, 36.36%
  3. Lisinopril: 3 people, 27.27%
  4. Aspirin: 2 people, 18.18%
  5. Trilipix: 1 person, 9.09%
  6. Amaryl: 1 person, 9.09%
  7. Byetta: 1 person, 9.09%
  8. Centrum Silver: 1 person, 9.09%
  9. Excedrin: 1 person, 9.09%
  10. Fish Oil: 1 person, 9.09%

Common side effects people have besides Skin blushing/flushing *:

  1. Blood Glucose Increased: 6 people, 54.55%
  2. Heart Attack: 2 people, 18.18%
  3. Nausea (feeling of having an urge to vomit): 2 people, 18.18%
  4. Dizziness: 2 people, 18.18%
  5. Heart Rate Increased: 2 people, 18.18%
  6. Generalised Erythema (redness of the skin all over the body): 1 person, 9.09%
  7. Adverse Drug Reaction: 1 person, 9.09%
  8. Back Pain: 1 person, 9.09%
  9. Burning Sensation: 1 person, 9.09%
  10. Chills (felling of cold): 1 person, 9.09%

Common conditions people have *:

  1. High Blood Cholesterol: 4 people, 36.36%
  2. Type 2 Diabetes: 2 people, 18.18%
  3. High Density Lipoprotein Decreased: 2 people, 18.18%
  4. Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 9.09%
  5. High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Avandaryl and have Skin blushing/flushing?

Check whether Skin blushing/flushing is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Avandaryl:

Skin blushing/flushing treatments and more:

COVID vaccines that are related to Skin blushing/flushing:

How severe was Skin blushing/flushing and when was it recovered:

Expand to all the drugs that have ingredients of glimepiride; rosiglitazone maleate:

Common drugs associated with Skin blushing/flushing:

All the drugs that are associated with Skin blushing/flushing:

Common conditions associated with Skin blushing/flushing:

All the conditions that are associated with Skin blushing/flushing:

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride; rosiglitazone maleate (the active ingredients of Avandaryl) and Avandaryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: